Lamassubiotech
Biologics & Biosimilars · Drug Discovery
Overview
ADVANCING NOVEL THERAPEUTICS TO ADDRESS UNMET NEEDS. A Patient-Centric Approach Leveraging Novel and Targeted Strategies With High Potential for Clinical Success.
Key facts
These are the key facts about Lamassubiotech on Alion as of Nov 13, 2026. Lamassubiotech is headquartered in Durham, United States. The latest round is Venture - Series Unknown of $2.7M, announced in 2020.
- Headquarters
- Durham, United StatesAlion company profile, updated Nov 12, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $2.7MSum of 1 equity round Alion knows
- Latest round
- Venture - Series Unknown · $2.7M · Apr 21, 2020SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$2.7M
4 rounds on record
Latest round
$2.7M
Venture round · Apr 2020 · 6 yr ago
Team
11-50
employees, estimated range
Grants
$5.3M
3 grants · CORDIS
The money's age
Long since its last round
78 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 1, 2024
Won a grant $1.7M · CORDIS
Aug 7, 2023
Won a grant $2M · CORDIS
Jul 7, 2020
Won a grant $1.6M · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Jul 2024 | $1.7M | — | CORDIS |
| Grant | Aug 2023 | $2M | — | CORDIS |
| Grant | Jul 2020 | $1.6M | — | CORDIS |
| Venture round | Apr 2020 | $2.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Lamassu Pharma, LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Gabi HannaExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key…
About the technology. Optimeos is developing a solution suite to overcome crucial formulation challenges and address unmet medical needs.
We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Theradaptive aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision.
"We are committed to creating the future of oncology by developing innovative therapies inducing autophagy to address unmet medical needs".
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
People
Gabi Hanna
Executive Officer, Director
Gregory Palmer
Director
Rabi Hanna
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Durham
United States
HQ
10-50 est. staff
How to cite this page
Alion, "Lamassubiotech: key facts", as of Nov 13, 2026. https://alion.io/company/lamassubiotech
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0